ScienceDex / Researcher record
Michael Ohlmeyer
- Atux Iskay Group LLC (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,043,077 | 2 | #5,127 |
| 2025 | $828,594 | 1 | #19,566 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected2 records
- FY20251 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9968969Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2024 award records by amount
NIH award records listing Michael Ohlmeyer as a PI. Multi-PI records show the full award amount for context.
- 2R44AG071040-02R44Contact PIDirect protein phosphatase 2A (PP2A) activators as novel Alzheimer’s Disease (AD) therapeutics$1.7Maward amount
- 75N91024C00009-0-9999-1N43Contact PISBIR CONCEPT AWARD - THERAPEUTICS - SULFONYL-UREA AND SULFONAMIDE PP2A ACTIVATORS AS MYCN AMPLIFIED NEUROBLASTOMA (NBL) THERAPEUTICS$355Kaward amount
Award organization
Organizations that administered FY2024 awards listing Michael Ohlmeyer as a PI.
FY2024 award administered by Atux Iskay Group LLC (NJ).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardAtux Iskay Group LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5127